Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetically modified allergens.

Verena Niederberger1, Rudolf Valenta

  • 1Department of Otorhinolaryngology, Vienna General Hospital, Medical University of Vienna, Ebene 8J, Waehringer Guertel 18-20, Vienna A-1090, Austria. verena.niederberger@meduniwien.ac.at

Immunology and Allergy Clinics of North America
|October 12, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Involution of IgE sensitization to house dust mite allergen molecules by age.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same author

Irritant occupational exposure and specific-IgE sensitisation in the EGEA cohort.

Occupational and environmental medicine·2026
Same author

Discovery of tumor antigens in renal cell carcinoma and prospects for clinical application.

Frontiers in immunology·2026
Same author

Birch Pollen Exposure Boosts Mal d 1-Specific IgE and Sensitivity to Apple.

Allergy·2026
Same author

Reply.

The Journal of allergy and clinical immunology·2026
Same author

Algorithms in Allergy: General Allergen Molecule-Based Algorithm for Allergen-Specific Immunotherapy.

Allergy·2026
Same journal

Anaphylaxis: State-of-the-Art.

Immunology and allergy clinics of North America·2026
Same journal

Upending Impending Doom.

Immunology and allergy clinics of North America·2026
Same journal

Mast Cell Activation Syndrome and Mimickers.

Immunology and allergy clinics of North America·2026
Same journal

Hereditary Alpha-Tryptasemia (HαT) as a Risk Modifier for Severe Anaphylaxis.

Immunology and allergy clinics of North America·2026
Same journal

Emerging Therapies for Anaphylaxis.

Immunology and allergy clinics of North America·2026
Same journal

Novel Epinephrine Delivery Devices.

Immunology and allergy clinics of North America·2026
See all related articles

Recombinant allergens offer a novel approach to allergy treatment, improving upon traditional immunotherapy. These modified allergens enhance safety and efficacy for personalized allergy care.

Area of Science:

  • Allergy and Immunology
  • Molecular Biology
  • Biotechnology

Background:

  • Allergen-specific immunotherapy (ASIT) is the only causative allergy treatment, but has seen little innovation in 90 years.
  • Advances in molecular biology enable the production of recombinant allergens.
  • Recombinant allergens allow for personalized sensitization profiling in allergic patients.

Purpose of the Study:

  • To review the development and application of genetically modified recombinant allergen derivatives.
  • To highlight the potential of these derivatives in improving ASIT safety and efficacy.
  • To discuss novel therapeutic tools for allergy management.

Main Methods:

  • Utilizing molecular biology techniques to create recombinant allergen derivatives.

Related Experiment Videos

  • Modifying allergens to reduce their allergenic activity.
  • Summarizing existing data on genetically modified allergens.

    • Main Results:

    • Recombinant allergens can be produced from major allergen sources.
    • Genetically modified allergen derivatives show reduced allergenic activity.
    • These derivatives offer potential for improved ASIT.

    Conclusions:

    • Recombinant allergens represent a significant advancement in allergy treatment.
    • Genetically modified allergen derivatives enhance the safety and efficacy of ASIT.
    • Novel therapeutic strategies are emerging for personalized allergy management.